Skip to main content
Erschienen in: Endocrine 2/2017

19.12.2016 | Review

Adrenal crises: perspectives and research directions

verfasst von: R. Louise Rushworth, David J. Torpy, Henrik Falhammar

Erschienen in: Endocrine | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Adrenal crises are life-threatening complications of adrenal insufficiency. These events have an estimated incidence of between 5 and 10  adrenal crises/100 patient years and are responsible for some of the increased morbidity and excess mortality experienced by patients with adrenal insufficiency. Treatment involves urgent administration of IV/IM hydrocortisone and IV fluids. Patient education regarding preventive measures, such as increasing the dose of replacement therapy (“stress dosing”) when sick, using parenteral hydrocortisone as necessary and accessing medical assistance promptly, is still considered the best approach to averting the onset of an adrenal crisis at times of physiological stress, most commonly an infection. However, recent evidence has demonstrated that patient education does not prevent many adrenal crisis events and the reasons for this are not fully understood. Furthermore, there is no widely accepted definition of an adrenal crisis. Without a validated adrenal crisis definition it is difficult to interpret variations in the incidence of adrenal crises and determine the effectiveness of preventive measures. This article aims to review the clinical aspects of adrenal crisis events, to explore the epidemiology, and to offer a definition of an adrenal crisis and to offer a perspective on future directions for research into adrenal crisis prevention.
Literatur
1.
Zurück zum Zitat M.M. Erichsen, K. Lovas, K.J. Fougner, J. Svartberg, E.R. Hauge, J. Bollerslev, J.P. Berg, B. Mella, E.S. Husebye, Normal overall mortality rate in Addison’s disease, but young patients are at risk of premature death. Eur. J. Endocrinol. 160, 233–237 (2009)CrossRefPubMed M.M. Erichsen, K. Lovas, K.J. Fougner, J. Svartberg, E.R. Hauge, J. Bollerslev, J.P. Berg, B. Mella, E.S. Husebye, Normal overall mortality rate in Addison’s disease, but young patients are at risk of premature death. Eur. J. Endocrinol. 160, 233–237 (2009)CrossRefPubMed
2.
Zurück zum Zitat H. Falhammar, L. Frisén, C. Norrby, A.L. Hirschberg, C. Almqvist, A. Nordenskjöld, A. Nordenström, Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 99(12), E2715–E2721 (2014)CrossRefPubMed H. Falhammar, L. Frisén, C. Norrby, A.L. Hirschberg, C. Almqvist, A. Nordenskjöld, A. Nordenström, Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 99(12), E2715–E2721 (2014)CrossRefPubMed
3.
Zurück zum Zitat P. Burman, A.F. Mattsson, G. Johannsson, C. Höybye, H. Holmer, P. Dahlqvist, K. Berinder, B.E. Engström, B. Ekman, E.M. Erfurth, J. Svensson, J. Wahlberg, F.A. Karlsson, Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J. Clin. Endocrinol. Metab. 98(4), 1466–1475 (2013)CrossRefPubMed P. Burman, A.F. Mattsson, G. Johannsson, C. Höybye, H. Holmer, P. Dahlqvist, K. Berinder, B.E. Engström, B. Ekman, E.M. Erfurth, J. Svensson, J. Wahlberg, F.A. Karlsson, Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J. Clin. Endocrinol. Metab. 98(4), 1466–1475 (2013)CrossRefPubMed
4.
Zurück zum Zitat R. Bergthorsdottir, M. Leonsson-Zachrisson, A. Oden, G. Johannsson, Premature mortality in patients with Addison’s disease: a population-based study. J. Clin. Endocrinol. Metab. 91, 4849–4853 (2006)CrossRefPubMed R. Bergthorsdottir, M. Leonsson-Zachrisson, A. Oden, G. Johannsson, Premature mortality in patients with Addison’s disease: a population-based study. J. Clin. Endocrinol. Metab. 91, 4849–4853 (2006)CrossRefPubMed
5.
Zurück zum Zitat J.W. Tomlinson, N. Holden, R.K. Hills, K. Wheatley, R.N. Clayton, A.S. Bates, M.C. Sheppard, P.M. Stewart, Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet. 357(9254), 425–431 (2001)CrossRefPubMed J.W. Tomlinson, N. Holden, R.K. Hills, K. Wheatley, R.N. Clayton, A.S. Bates, M.C. Sheppard, P.M. Stewart, Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet. 357(9254), 425–431 (2001)CrossRefPubMed
6.
Zurück zum Zitat S. Bensing, L. Brandt, F. Tabaroj, O. Sjoberg, B. Nilsson, A. Ekbom, P. Blomqvist, O. Kampe, Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin. Endocrinol. (Oxf). 69, 697–704 (2008)CrossRef S. Bensing, L. Brandt, F. Tabaroj, O. Sjoberg, B. Nilsson, A. Ekbom, P. Blomqvist, O. Kampe, Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin. Endocrinol. (Oxf). 69, 697–704 (2008)CrossRef
7.
Zurück zum Zitat S. Hahner, C. Spinnler, M. Fassnacht, S. Burger-Stritt, K. Lang, D. Milovanovic, F. Beuschlein, H.S. Willenberg, M. Quinkler, B. Allolio, High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J. Clin. Endocrinol. Metab. 100(2), 407–416 (2015)CrossRefPubMed S. Hahner, C. Spinnler, M. Fassnacht, S. Burger-Stritt, K. Lang, D. Milovanovic, F. Beuschlein, H.S. Willenberg, M. Quinkler, B. Allolio, High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J. Clin. Endocrinol. Metab. 100(2), 407–416 (2015)CrossRefPubMed
8.
Zurück zum Zitat S.C. Chapman, S. Llahana, P. Carroll, R. Horne, Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and dissatisfaction with information. Clin. Endocrinol. (Oxf). 84(5), 664–671 (2016)CrossRefPubMed S.C. Chapman, S. Llahana, P. Carroll, R. Horne, Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and dissatisfaction with information. Clin. Endocrinol. (Oxf). 84(5), 664–671 (2016)CrossRefPubMed
9.
Zurück zum Zitat A. Gargya, E. Chua, J. Hetherington, K. Sommer, M. Cooper, Acute adrenal insufficiency: an aide-memoire of the critical importance of its recognition and prevention. Intern. Med. J. 46(3), 356–359 (2016)CrossRefPubMed A. Gargya, E. Chua, J. Hetherington, K. Sommer, M. Cooper, Acute adrenal insufficiency: an aide-memoire of the critical importance of its recognition and prevention. Intern. Med. J. 46(3), 356–359 (2016)CrossRefPubMed
10.
Zurück zum Zitat B. Allolio, Extensive experience in endocrinology: adrenal crisis. Eur. J. Endocrinol. 172, R115–R124 (2015)CrossRefPubMed B. Allolio, Extensive experience in endocrinology: adrenal crisis. Eur. J. Endocrinol. 172, R115–R124 (2015)CrossRefPubMed
11.
Zurück zum Zitat S. Hahner, M. Loeffler, B. Bleicken, C. Drechsler, D. Milovanovic, M. Fassnacht, M. Ventz, M. Quinkler, B. Allolio, Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur. J. Endocrinol. 162(3), 597–602 (2010)CrossRefPubMed S. Hahner, M. Loeffler, B. Bleicken, C. Drechsler, D. Milovanovic, M. Fassnacht, M. Ventz, M. Quinkler, B. Allolio, Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur. J. Endocrinol. 162(3), 597–602 (2010)CrossRefPubMed
12.
Zurück zum Zitat B. Odenwald, U. Nennstiel-Ratzel, H.G. Dörr, H. Schmidt, M. Wildner, W. Bonfig, Children with classic congenital adrenal hyperplasia experience salt loss and hypoglycemia: evaluation of adrenal crises during the first 6 years of life. Eur. J. Endocrinol. 174(2), 177–186 (2016)PubMed B. Odenwald, U. Nennstiel-Ratzel, H.G. Dörr, H. Schmidt, M. Wildner, W. Bonfig, Children with classic congenital adrenal hyperplasia experience salt loss and hypoglycemia: evaluation of adrenal crises during the first 6 years of life. Eur. J. Endocrinol. 174(2), 177–186 (2016)PubMed
13.
Zurück zum Zitat L.C. Smans, E.S. Van der Valk, A.R. Hermus, P.M. Zelissen, Incidence of adrenal crisis in patients with adrenal insufficiency. Clin. Endocrinol. (Oxf). 84(1), 17–22 (2016)CrossRefPubMed L.C. Smans, E.S. Van der Valk, A.R. Hermus, P.M. Zelissen, Incidence of adrenal crisis in patients with adrenal insufficiency. Clin. Endocrinol. (Oxf). 84(1), 17–22 (2016)CrossRefPubMed
14.
Zurück zum Zitat K. Ritzel, F. Beuschlein, A. Mickisch, A. Osswald, H.J. Schneider, J. Schopohl, M. Reincke, Clinical review: outcome of bilateral adrenalectomy in Cushing’s syndrome: a systematic review. J. Clin. Endocrinol. Metab. 98, 3939–3948 (2013)CrossRefPubMed K. Ritzel, F. Beuschlein, A. Mickisch, A. Osswald, H.J. Schneider, J. Schopohl, M. Reincke, Clinical review: outcome of bilateral adrenalectomy in Cushing’s syndrome: a systematic review. J. Clin. Endocrinol. Metab. 98, 3939–3948 (2013)CrossRefPubMed
15.
Zurück zum Zitat N. Reisch, M. Willige, D. Kohn, H.P. Schwarz, B. Allolio, M. Reincke, M. Quinkler, S. Hahner, F. Beuschlein, Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. Eur. J. Endocrinol. 167(1), 35–42 (2012)CrossRefPubMed N. Reisch, M. Willige, D. Kohn, H.P. Schwarz, B. Allolio, M. Reincke, M. Quinkler, S. Hahner, F. Beuschlein, Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. Eur. J. Endocrinol. 167(1), 35–42 (2012)CrossRefPubMed
16.
Zurück zum Zitat G. Meyer, K. Badenhoop, R. Linder, Addison’s disease with polyglandular autoimmunity carries a more than 2.5-fold risk for adrenal crises: German Health insurance data 2010-2013. Clin. Endocrinol. (Oxf). 85(3), 347–353 (2016)CrossRefPubMed G. Meyer, K. Badenhoop, R. Linder, Addison’s disease with polyglandular autoimmunity carries a more than 2.5-fold risk for adrenal crises: German Health insurance data 2010-2013. Clin. Endocrinol. (Oxf). 85(3), 347–353 (2016)CrossRefPubMed
17.
Zurück zum Zitat L. Papierska, M. Rabijewski, Delay in diagnosis of adrenal insufficiency is a frequent cause of adrenal crisis. Int J Endocrinol 2013, 482370 (2013)CrossRefPubMedPubMedCentral L. Papierska, M. Rabijewski, Delay in diagnosis of adrenal insufficiency is a frequent cause of adrenal crisis. Int J Endocrinol 2013, 482370 (2013)CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat S. Gidlöf, H. Falhammar, A. Thilén, U. von Döbeln, M. Ritzén, A. Wedell, A. Nordenström, One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study. Lancet Diabetes Endocrinol. 1(1), 35–42 (2013)CrossRefPubMed S. Gidlöf, H. Falhammar, A. Thilén, U. von Döbeln, M. Ritzén, A. Wedell, A. Nordenström, One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study. Lancet Diabetes Endocrinol. 1(1), 35–42 (2013)CrossRefPubMed
19.
Zurück zum Zitat R.L. Rushworth, D.J. Torpy, A descriptive study of adrenal crises in adults with adrenal insufficiency: increased risk with age and in those with bacterial infections. BMC. Endocr. Disord. 14, 79 (2014)CrossRefPubMedPubMedCentral R.L. Rushworth, D.J. Torpy, A descriptive study of adrenal crises in adults with adrenal insufficiency: increased risk with age and in those with bacterial infections. BMC. Endocr. Disord. 14, 79 (2014)CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat J.S. Bromberg, E.J. Alfrey, C.F. Barker, K.D. Chavin, D.C. Dafoe, T. Holland, A. Naji, L.J. Perloff, L.A. Zellers, R.A. Grossman, Adrenal suppression and steroid supplementation in renal transplant recipients. J. Transpl. 31, 385–390 (1991)CrossRef J.S. Bromberg, E.J. Alfrey, C.F. Barker, K.D. Chavin, D.C. Dafoe, T. Holland, A. Naji, L.J. Perloff, L.A. Zellers, R.A. Grossman, Adrenal suppression and steroid supplementation in renal transplant recipients. J. Transpl. 31, 385–390 (1991)CrossRef
21.
Zurück zum Zitat K. White, W. Arlt, Adrenal crisis in treated Addison’s disease: a predictable but under-managed event. Eur. J. Endocrinol. 162(1), 115–120 (2010)CrossRefPubMed K. White, W. Arlt, Adrenal crisis in treated Addison’s disease: a predictable but under-managed event. Eur. J. Endocrinol. 162(1), 115–120 (2010)CrossRefPubMed
22.
Zurück zum Zitat World Health Organisation: International statistical classification of diseases and health related problems, 10th Revision (ICD 10). Geneva: WHO (2011) World Health Organisation: International statistical classification of diseases and health related problems, 10th Revision (ICD 10). Geneva: WHO (2011)
23.
Zurück zum Zitat S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer, E.S. Husebye, D.P. Merke, M.H. Murad, C.A. Stratakis, D.J. Torpy, Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 101(2), 364–389 (2016)CrossRefPubMed S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer, E.S. Husebye, D.P. Merke, M.H. Murad, C.A. Stratakis, D.J. Torpy, Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 101(2), 364–389 (2016)CrossRefPubMed
24.
Zurück zum Zitat T.H. Puar, N.M. Stikkelbroeck, L.C. Smans, P.M. Zelissen, A.R. Hermus, Adrenal crisis: still a deadly event in the 21(st) century. Am. J. Med. 129(3), 339.e1–e9 (2016)CrossRef T.H. Puar, N.M. Stikkelbroeck, L.C. Smans, P.M. Zelissen, A.R. Hermus, Adrenal crisis: still a deadly event in the 21(st) century. Am. J. Med. 129(3), 339.e1–e9 (2016)CrossRef
25.
Zurück zum Zitat I.J. Elenkov, R.L. Wilder, G.P. Chrousos, E.S. Vizi, The sympathetic nerve—an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52(4), 595–638 (2000)PubMed I.J. Elenkov, R.L. Wilder, G.P. Chrousos, E.S. Vizi, The sympathetic nerve—an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52(4), 595–638 (2000)PubMed
26.
Zurück zum Zitat R.C. Andrews, O. Herlihy, D.E. Livingstone, R. Andrew, B.R. Walker, Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J. Clin. Endocrinol. Metab. 87(12), 5587–5593 (2002)CrossRefPubMed R.C. Andrews, O. Herlihy, D.E. Livingstone, R. Andrew, B.R. Walker, Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J. Clin. Endocrinol. Metab. 87(12), 5587–5593 (2002)CrossRefPubMed
27.
Zurück zum Zitat J.E. Zimmerman, A.A. Kramer, D.S. McNair, F.M. Malila, Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today’s critically ill patients. Crit. Care. Med. 34(5), 1297–1210 (2006)CrossRefPubMed J.E. Zimmerman, A.A. Kramer, D.S. McNair, F.M. Malila, Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today’s critically ill patients. Crit. Care. Med. 34(5), 1297–1210 (2006)CrossRefPubMed
28.
Zurück zum Zitat D. Naik, K.F. Jebasingh, N. Thomas, Delayed diagnosis of graves’ thyrotoxicoisis presenting as recurrent adrenal crisis in primary adrenal insufficiency. J. Clin. Diagn. Res 10(4), OD20–OD22 (2016)PubMedPubMedCentral D. Naik, K.F. Jebasingh, N. Thomas, Delayed diagnosis of graves’ thyrotoxicoisis presenting as recurrent adrenal crisis in primary adrenal insufficiency. J. Clin. Diagn. Res 10(4), OD20–OD22 (2016)PubMedPubMedCentral
29.
Zurück zum Zitat R.L. Rushworth, D.J. Torpy, Adrenal insufficiency in Australia: is it possible that the use of lower dose, short-acting glucocorticoids has increased the risk of adrenal crises? Horm. Metab. Res 47(6), 427–432 (2015)CrossRefPubMed R.L. Rushworth, D.J. Torpy, Adrenal insufficiency in Australia: is it possible that the use of lower dose, short-acting glucocorticoids has increased the risk of adrenal crises? Horm. Metab. Res 47(6), 427–432 (2015)CrossRefPubMed
30.
Zurück zum Zitat A.A. Nofal, I. Bancos, K. Benkhadra, N.M. Ospina, A. Javed, Kapoor E, Muthusamy K, Brito JP, Turcu AF, Wang Z, Prokop L, Erickson DZ, Lteif AN, Natt N, Murad MH. Glucocorticoid replacement regimens in chronic adrenal insufficiency: a systematic review and meta-analysis. Endocr. Pract. (2016) Sep 15 [Epub ahead of print] A.A. Nofal, I. Bancos, K. Benkhadra, N.M. Ospina, A. Javed, Kapoor E, Muthusamy K, Brito JP, Turcu AF, Wang Z, Prokop L, Erickson DZ, Lteif AN, Natt N, Murad MH. Glucocorticoid replacement regimens in chronic adrenal insufficiency: a systematic review and meta-analysis. Endocr. Pract. (2016) Sep 15 [Epub ahead of print]
31.
Zurück zum Zitat D.J. Torpy Glucocorticoid replacement in adrenal insufficiency; evaluating the evidence for optimal therapy. Endocr. Pract. (2016) On Line before print. doi:10.4158/EP161591.CO D.J. Torpy Glucocorticoid replacement in adrenal insufficiency; evaluating the evidence for optimal therapy. Endocr. Pract. (2016) On Line before print. doi:10.​4158/​EP161591.​CO
32.
Zurück zum Zitat Y. Reznik, Therapeutic innovations in endocrine diseases—Part 2: modified-release glucocorticoid compounds: what good do they provide to the adrenal insufficient patient? Presse. Med. 45(6 Pt 2), e205–e210 (2016)CrossRefPubMed Y. Reznik, Therapeutic innovations in endocrine diseases—Part 2: modified-release glucocorticoid compounds: what good do they provide to the adrenal insufficient patient? Presse. Med. 45(6 Pt 2), e205–e210 (2016)CrossRefPubMed
33.
Zurück zum Zitat R.L. Rushworth, H. Falhammar, C.F. Munns, A.M. Maguire, D.J. Torpy, Hospitalisation in children with Congenital Adrenal Hyperplasia: the importance of younger age, viral infections and acute hypoadrenalism. Int. J. Endocrinol. (2016). doi:10.1155/2016/5748264 R.L. Rushworth, H. Falhammar, C.F. Munns, A.M. Maguire, D.J. Torpy, Hospitalisation in children with Congenital Adrenal Hyperplasia: the importance of younger age, viral infections and acute hypoadrenalism. Int. J. Endocrinol. (2016). doi:10.​1155/​2016/​5748264
34.
Zurück zum Zitat I.J. Elenkov, D.G. Iezzoni, A. Daly, A.G. Harris, G.P. Chrousos, Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation. 12(5), 255–269 (2005)CrossRefPubMed I.J. Elenkov, D.G. Iezzoni, A. Daly, A.G. Harris, G.P. Chrousos, Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation. 12(5), 255–269 (2005)CrossRefPubMed
35.
Zurück zum Zitat S. Yang, L. Zhang, Glucocorticoids and vascular reactivity. Curr. Vasc. Pharmacol. 2(1), 1–12 (2004)CrossRefPubMed S. Yang, L. Zhang, Glucocorticoids and vascular reactivity. Curr. Vasc. Pharmacol. 2(1), 1–12 (2004)CrossRefPubMed
36.
Zurück zum Zitat M. Quinkler, P. Dahlqvist, E.S. Husebye, O.A. Kämpe, European emergency card for adrenal insufficiency can save lives. Eur. J. Intern. Med. 1(1), 75–76 (2015)CrossRef M. Quinkler, P. Dahlqvist, E.S. Husebye, O.A. Kämpe, European emergency card for adrenal insufficiency can save lives. Eur. J. Intern. Med. 1(1), 75–76 (2015)CrossRef
37.
Zurück zum Zitat S. Hahner, S. Burger-Stritt, B. Allolio, Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency. Eur. J. Endocrinol. 169(2), 147–154 (2013)CrossRefPubMed S. Hahner, S. Burger-Stritt, B. Allolio, Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency. Eur. J. Endocrinol. 169(2), 147–154 (2013)CrossRefPubMed
38.
Zurück zum Zitat R.L. Rushworth, C. Bischoff, D.J. Torpy, Preventing adrenal crises—home administered subcutaneous hydrocortisone is an option. Int. Med. Journal (in press) R.L. Rushworth, C. Bischoff, D.J. Torpy, Preventing adrenal crises—home administered subcutaneous hydrocortisone is an option. Int. Med. Journal (in press)
39.
Zurück zum Zitat B. Harbeck, S. Brede, C. Witt, S. Süfke, H. Lehnert, C. Haas, Glucocorticoid replacement therapy in adrenal insufficiency—a challenge to physicians? Endocr. J. 62(5), 463–468 (2015)CrossRefPubMed B. Harbeck, S. Brede, C. Witt, S. Süfke, H. Lehnert, C. Haas, Glucocorticoid replacement therapy in adrenal insufficiency—a challenge to physicians? Endocr. J. 62(5), 463–468 (2015)CrossRefPubMed
40.
Zurück zum Zitat D. Kampmeyer, H. Lehnert, H. Moenig, C.S. Haas, B. Harbeck, A strong need for improving the education of physicians on glucocorticoid replacement treatment in adrenal insufficiency: an interdisciplinary and multicentre evaluation. Eur. J. Intern. Med. S0953-6205(16), 30075–30079 (2016) D. Kampmeyer, H. Lehnert, H. Moenig, C.S. Haas, B. Harbeck, A strong need for improving the education of physicians on glucocorticoid replacement treatment in adrenal insufficiency: an interdisciplinary and multicentre evaluation. Eur. J. Intern. Med. S0953-6205(16), 30075–30079 (2016)
41.
Zurück zum Zitat S. Hahner, N. Hemmelmann, M. Quinkler, F. Beuschlein, C. Spinnler, B. Allolio, Timelines in the management of adrenal crisis—targets, limits and reality. Clin. Endocrinol. (Oxf). 82(4), 497–502 (2015)CrossRefPubMed S. Hahner, N. Hemmelmann, M. Quinkler, F. Beuschlein, C. Spinnler, B. Allolio, Timelines in the management of adrenal crisis—targets, limits and reality. Clin. Endocrinol. (Oxf). 82(4), 497–502 (2015)CrossRefPubMed
42.
Zurück zum Zitat M.A. Nenke, W. Rankin, M.J. Chapman, N.E. Stevens, K.R. Diener, J.D. Hayball, J.G. Lewis, D.J. Torpy, Depletion of high-affinity corticosteroid-binding globulin corresponds to illness severity in sepsis and septic shock; clinical implications. Clin. Endocrinol. (Oxf). 82(6), 801–807 (2015)CrossRefPubMed M.A. Nenke, W. Rankin, M.J. Chapman, N.E. Stevens, K.R. Diener, J.D. Hayball, J.G. Lewis, D.J. Torpy, Depletion of high-affinity corticosteroid-binding globulin corresponds to illness severity in sepsis and septic shock; clinical implications. Clin. Endocrinol. (Oxf). 82(6), 801–807 (2015)CrossRefPubMed
43.
Zurück zum Zitat E.J. Meyer, M.A. Nenke, W. Rankin, J.G. Lewis, D.J. Torpy, Corticosteroid-binding globulin: a review of basic and clinical advances. Horm. Metab. Res. 48(06), 359–371 (2016)CrossRefPubMed E.J. Meyer, M.A. Nenke, W. Rankin, J.G. Lewis, D.J. Torpy, Corticosteroid-binding globulin: a review of basic and clinical advances. Horm. Metab. Res. 48(06), 359–371 (2016)CrossRefPubMed
44.
Zurück zum Zitat K. Betito, J. Diorio, M.J. Meaney, P. Boksa, Adrenal phenylethanolamine N-methyltransferase induction in relation to glucocorticoid receptor dynamics: evidence that acute exposure to high cortisol levels is sufficient to induce the enzyme. J. Neurochem. 58(5), 1853–1862 (1992)CrossRefPubMed K. Betito, J. Diorio, M.J. Meaney, P. Boksa, Adrenal phenylethanolamine N-methyltransferase induction in relation to glucocorticoid receptor dynamics: evidence that acute exposure to high cortisol levels is sufficient to induce the enzyme. J. Neurochem. 58(5), 1853–1862 (1992)CrossRefPubMed
45.
Zurück zum Zitat H. Falhammar, H. Filipsson Nystrom, A. Wedell, M. Thoren, Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adcrenal hyperplasia due to hydroxylase deficiency. Eur. J. Endocrinol. 164(2), 285–293 (2011)CrossRefPubMed H. Falhammar, H. Filipsson Nystrom, A. Wedell, M. Thoren, Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adcrenal hyperplasia due to hydroxylase deficiency. Eur. J. Endocrinol. 164(2), 285–293 (2011)CrossRefPubMed
46.
Zurück zum Zitat E. Charmandari, G. Eisenhofer, S.L. Mehlinger, A. Carlson, R. Wesley, M.F. Keil, G.P. Chrousos, M.I. New, D.P. Merke, Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 87(7), 3031–3037 (2002)CrossRefPubMed E. Charmandari, G. Eisenhofer, S.L. Mehlinger, A. Carlson, R. Wesley, M.F. Keil, G.P. Chrousos, M.I. New, D.P. Merke, Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 87(7), 3031–3037 (2002)CrossRefPubMed
47.
Zurück zum Zitat H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjöld, K. Hagenfeldt, M. Thorén, Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92(1), 110–116 (2007)CrossRefPubMed H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjöld, K. Hagenfeldt, M. Thorén, Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92(1), 110–116 (2007)CrossRefPubMed
48.
Zurück zum Zitat H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjöld, K. Hagenfeldt, M. Thorén, Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. J. 56(4), 601–608 (2009)CrossRefPubMed H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjöld, K. Hagenfeldt, M. Thorén, Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. J. 56(4), 601–608 (2009)CrossRefPubMed
49.
50.
Zurück zum Zitat G. Meyer, A. Hackemann, J. Reusch, K. Badenhoop, Nocturnal hypoglycemia identified by a continuous glucose monitoring system in patients with primary adrenal insufficiency (Addison’s disease). Diabetes Technol. Ther. 14(5), 386–388 (2012)CrossRefPubMedPubMedCentral G. Meyer, A. Hackemann, J. Reusch, K. Badenhoop, Nocturnal hypoglycemia identified by a continuous glucose monitoring system in patients with primary adrenal insufficiency (Addison’s disease). Diabetes Technol. Ther. 14(5), 386–388 (2012)CrossRefPubMedPubMedCentral
51.
52.
Zurück zum Zitat R.L. Rushworth, D.J. Torpy, Modern hydrocortisone replacement regimens in adrenal insufficiency patients and the risk of adrenal crisis. Horm. Metab. Res. 47(9), 637–642 (2015)CrossRefPubMed R.L. Rushworth, D.J. Torpy, Modern hydrocortisone replacement regimens in adrenal insufficiency patients and the risk of adrenal crisis. Horm. Metab. Res. 47(9), 637–642 (2015)CrossRefPubMed
53.
Zurück zum Zitat G. Meyer, K. Neumann, K. Badenhoop, R. Linder, Increasing prevalence of Addison’s disease in German females: health insurance data 2008-2012. Eur. J. Endocrinol. 170, 367–373 (2014)CrossRefPubMed G. Meyer, K. Neumann, K. Badenhoop, R. Linder, Increasing prevalence of Addison’s disease in German females: health insurance data 2008-2012. Eur. J. Endocrinol. 170, 367–373 (2014)CrossRefPubMed
54.
Zurück zum Zitat R.L. Rushworth, P. Slobodian, D.J. Torpy, Interruptions to supply of high-dose hydrocortisone tablets and the incidence of adrenal crises. Clin. Endocrinol. (Oxf). 83(6), 999–1000 (2015)CrossRefPubMed R.L. Rushworth, P. Slobodian, D.J. Torpy, Interruptions to supply of high-dose hydrocortisone tablets and the incidence of adrenal crises. Clin. Endocrinol. (Oxf). 83(6), 999–1000 (2015)CrossRefPubMed
Metadaten
Titel
Adrenal crises: perspectives and research directions
verfasst von
R. Louise Rushworth
David J. Torpy
Henrik Falhammar
Publikationsdatum
19.12.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1204-2

Weitere Artikel der Ausgabe 2/2017

Endocrine 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.